BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28574616)

  • 1. The Therapeutic Potential of Targeting Tumor Microenvironment in Breast Cancer: Rational Strategies and Recent Progress.
    Bahrami A; Hassanian SM; Khazaei M; Hasanzadeh M; Shahidsales S; Maftouh M; Ferns GA; Avan A
    J Cell Biochem; 2018 Jan; 119(1):111-122. PubMed ID: 28574616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy.
    Truffi M; Mazzucchelli S; Bonizzi A; Sorrentino L; Allevi R; Vanna R; Morasso C; Corsi F
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies.
    Zarrilli G; Businello G; Dieci MV; Paccagnella S; Carraro V; Cappellesso R; Miglietta F; Griguolo G; Guarneri V; Lo Mele M; Fassan M
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets.
    Nienhuis HH; Gaykema SB; Timmer-Bosscha H; Jalving M; Brouwers AH; Lub-de Hooge MN; van der Vegt B; Overmoyer B; de Vries EG; Schröder CP
    Pharmacol Ther; 2015 Mar; 147():63-79. PubMed ID: 25444756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis.
    Xie HY; Shao ZM; Li DQ
    Chin J Cancer; 2017 Mar; 36(1):36. PubMed ID: 28356139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Microenvironment of Lung Cancer and Therapeutic Implications.
    Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
    Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics.
    Chen Q; Liu G; Liu S; Su H; Wang Y; Li J; Luo C
    Trends Pharmacol Sci; 2018 Jan; 39(1):59-74. PubMed ID: 29153879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the role of components of the tumor microenvironment in oral carcinoma call for new therapeutic approaches.
    Salo T; Vered M; Bello IO; Nyberg P; Bitu CC; Zlotogorski Hurvitz A; Dayan D
    Exp Cell Res; 2014 Jul; 325(2):58-64. PubMed ID: 24462456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.
    Tariq M; Zhang J; Liang G; Ding L; He Q; Yang B
    J Cell Biochem; 2017 Sep; 118(9):2484-2501. PubMed ID: 28106295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy.
    Lan M; Lu W; Zou T; Li L; Liu F; Cai T; Cai Y
    Cell Mol Life Sci; 2021 Mar; 78(5):2105-2129. PubMed ID: 33386887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
    Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
    Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.
    Radisky ES; Raeeszadeh-Sarmazdeh M; Radisky DC
    J Cell Biochem; 2017 Nov; 118(11):3531-3548. PubMed ID: 28585723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex interplay between tumor microenvironment and cancer therapy.
    Shen M; Kang Y
    Front Med; 2018 Aug; 12(4):426-439. PubMed ID: 30097962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells.
    Talarico G; Orecchioni S; Dallaglio K; Reggiani F; Mancuso P; Calleri A; Gregato G; Labanca V; Rossi T; Noonan DM; Albini A; Bertolini F
    Sci Rep; 2016 Jan; 6():18673. PubMed ID: 26728433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Normalization of the Tumor Microenvironment for Cancer Therapy.
    Zheng J; Gao P
    Integr Cancer Ther; 2019; 18():1534735419862352. PubMed ID: 31282197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Immunotherapy to the Tumor Microenvironment.
    Dougan M; Dougan SK
    J Cell Biochem; 2017 Oct; 118(10):3049-3054. PubMed ID: 28332219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cancer-associated fibroblasts in breast cancer pathobiology.
    Jung YY; Kim HM; Koo JS
    Histol Histopathol; 2016 Apr; 31(4):371-8. PubMed ID: 26627101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles designed to regulate tumor microenvironment for cancer therapy.
    Li M; Zhang F; Su Y; Zhou J; Wang W
    Life Sci; 2018 May; 201():37-44. PubMed ID: 29577880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of tumor stroma on drug response in breast cancer.
    Dittmer J; Leyh B
    Semin Cancer Biol; 2015 Apr; 31():3-15. PubMed ID: 24912116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.
    Weitzenfeld P; Meshel T; Ben-Baruch A
    Oncotarget; 2016 Dec; 7(49):81123-81143. PubMed ID: 27835603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.